• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于项目反应理论的改善阳性与阴性症状量表(PANSS)的建议。

Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.

机构信息

Bar Ilan University, Ramat Gan 52900, Israel.

出版信息

Psychiatry Res. 2011 Aug 15;188(3):446-52. doi: 10.1016/j.psychres.2011.03.014. Epub 2011 Apr 3.

DOI:10.1016/j.psychres.2011.03.014
PMID:21463902
Abstract

The adequacy of the Positive and Negative Syndrome Scale (PANSS) items in measuring symptom severity in schizophrenia was examined using Item Response Theory (IRT). Baseline PANSS assessments were analyzed from two multi-center clinical trials of antipsychotic medication in chronic schizophrenia (n=1872). Generally, the results showed that the PANSS (a) item ratings discriminated symptom severity best for the negative symptoms; (b) has an excess of "Severe" and "Extremely severe" rating options; and (c) assessments are more reliable at medium than very low or high levels of symptom severity. Analysis also showed that the detection of statistically and non-statistically significant differences in treatment were highly similar for the original and IRT-modified PANSS. In clinical trials of chronic schizophrenia, the PANSS appears to require the following modifications: fewer rating options, adjustment of 'Lack of judgment and insight', and improved severe symptom assessment.

摘要

采用项目反应理论(IRT)考察阳性和阴性症状量表(PANSS)项目在评估精神分裂症症状严重程度方面的充分性。对两项慢性精神分裂症抗精神病药物多中心临床试验的基线 PANSS 评估进行了分析(n=1872)。总体而言,结果表明,PANSS(a)项目评分对阴性症状的严重程度最佳区分;(b)有过多的“严重”和“极其严重”评分选项;(c)评估在中度症状严重程度时比非常低或高的水平更可靠。分析还表明,对于原始和 IRT 修正的 PANSS,在治疗中检测具有统计学和非统计学意义的差异高度相似。在慢性精神分裂症的临床试验中,PANSS 似乎需要进行以下修改:减少评分选项、调整“缺乏判断力和洞察力”,以及改进严重症状评估。

相似文献

1
Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory.基于项目反应理论的改善阳性与阴性症状量表(PANSS)的建议。
Psychiatry Res. 2011 Aug 15;188(3):446-52. doi: 10.1016/j.psychres.2011.03.014. Epub 2011 Apr 3.
2
Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.重新审视阳性与阴性症状量表的五个维度。
J Clin Psychopharmacol. 2007 Oct;27(5):431-6. doi: 10.1097/jcp/.0b013e31814cfabd.
3
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.在常规临床实践中,使用抗精神病药物治疗精神分裂症谱系障碍门诊患者的阴性症状患病率:CLAMORS 研究的结果。
J Clin Psychiatry. 2010 Mar;71(3):280-6. doi: 10.4088/JCP.08m04250yel. Epub 2009 Nov 3.
4
The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials.在4项精神分裂症试验的汇总分析中症状变化与治疗中断之间的时间关系。
J Clin Psychopharmacol. 2008 Oct;28(5):544-9. doi: 10.1097/JCP.0b013e318185e74a.
5
Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.佐替平与安慰剂治疗原发性阴性症状稳定的精神分裂症患者:一项随机双盲多中心试验。
Pharmacopsychiatry. 2004 Nov;37(6):270-8. doi: 10.1055/s-2004-832683.
6
Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.精神障碍患者亲属对精神病理学的标准化评估。使用阳性和阴性症状量表比较精神分裂症和情感障碍的初步结果。
Psychopathology. 2007;40(4):242-53. doi: 10.1159/000101729. Epub 2007 Apr 17.
7
The relationship between insight and symptoms in schizophrenia.精神分裂症中自知力与症状之间的关系。
Compr Psychiatry. 2004 Jan-Feb;45(1):16-9. doi: 10.1016/j.comppsych.2003.09.002.
8
[Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].[基于阳性和阴性症状量表(PANSS)及精神分裂症症状评定量表(SAPS)/精神分裂症阴性症状评定量表(SANS)结果的精神分裂症结构核心因素。PANSS与SAPS/SANS效度的辨别及直接比较]
Psychiatr Pol. 2004 Sep-Oct;38(5):795-808.
9
Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.齐拉西酮和阿立哌唑有效治疗精神分裂症的阴性症状:一项为期12周的双盲研究结果。 你提供的原文中药物名称有误,正确的应该是齐拉西酮(Ziprasidone)和阿立哌唑(Aripiprazole),我按照正确的药物名称进行了翻译。若按照你给定的原文“Ziprasidone and amisulpride”翻译,译文为“齐拉西酮和氨磺必利有效治疗精神分裂症的阴性症状:一项为期12周的双盲研究结果” 。
Int Clin Psychopharmacol. 2006 May;21(3):143-51. doi: 10.1097/01.yic.0000182121.59296.70.
10
Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.阴性症状评估量表(NSA - 16)变化与精神分裂症功能结局指标之间的关联。
Psychiatry Res. 2009 Sep 30;169(2):97-100. doi: 10.1016/j.psychres.2008.10.009. Epub 2009 Aug 7.

引用本文的文献

1
COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS).COSMIN对阳性和阴性症状量表(PANSS)测量属性的系统评价与Meta分析。
EClinicalMedicine. 2025 Apr 11;82:103155. doi: 10.1016/j.eclinm.2025.103155. eCollection 2025 Apr.
2
COSMIN review of the PANSS Marder factor solution and other factor models in people with schizophrenia.精神分裂症患者中阳性和阴性症状量表(PANSS)的马德因子解及其他因子模型的COSMIN综述。
Schizophrenia (Heidelb). 2025 Mar 31;11(1):51. doi: 10.1038/s41537-025-00600-6.
3
Shortening the Alzheimer's disease assessment scale cognitive subscale.
缩短阿尔茨海默病评估量表认知分量表。
Eur Psychiatry. 2024 Feb 23;67(1):e19. doi: 10.1192/j.eurpsy.2024.14.
4
Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout: a pooled participant-level analysis of 18 placebo-controlled risperidone and paliperidone trials.阳性和阴性症状量表(PANSS)-30、其主要子量表加 PANSS-6 的初始严重程度,以及与随后的改善和试验脱落的关系:18 项安慰剂对照利培酮和帕利哌酮试验的汇总参与者水平分析。
Transl Psychiatry. 2023 Jun 7;13(1):191. doi: 10.1038/s41398-023-02491-6.
5
Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration.简明阳性和阴性症状量表作为急性精神分裂症试验的替代临床终点:来自美国食品药品监督管理局的分析
Psychiatr Res Clin Pract. 2020 Nov 6;3(1):38-45. doi: 10.1176/appi.prcp.20200003. eCollection 2021 Spring.
6
Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.采用 Rasch 模型评估首发精神分裂症阳性与阴性综合征量表的可扩展性。
Acta Psychiatr Scand. 2022 Jul;146(1):21-35. doi: 10.1111/acps.13434. Epub 2022 Apr 22.
7
Brief Clinical Assessment Scale for Schizophrenia (BCASS): Development, Validity, and Reliability Study.精神分裂症简易临床评估量表(BCASS):编制、效度与信度研究
Noro Psikiyatr Ars. 2021 Aug 4;59(1):14-20. doi: 10.29399/npa.27592. eCollection 2022.
8
A very short Symptom Checklist-90-R version for routine outcome monitoring in psychotherapy; The SCL-3/7.一个非常简短的症状清单-90-R 版本,用于心理治疗中的常规结果监测; SCL-3/7。
Acta Psychiatr Scand. 2022 Apr;145(4):397-411. doi: 10.1111/acps.13396. Epub 2022 Feb 8.
9
Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis.与阳性和阴性症状量表(PANSS)-30相比,PANSS-6分量表上抗精神病药物与安慰剂的分离情况:一项汇总参与者水平分析
NPJ Schizophr. 2021 Aug 27;7(1):41. doi: 10.1038/s41537-021-00168-x.
10
The effects of systematic psychological nursing on the sleep quality of schizophrenic patients with sleep disorders.系统性心理护理对伴有睡眠障碍的精神分裂症患者睡眠质量的影响。
Am J Transl Res. 2021 Jun 15;13(6):7263-7269. eCollection 2021.